Ceftolozane/Tazobactam for Resistant Drugs Pseudomonas aeruginosa Respiratory Infections: A Systematic Literature Review of the Real-World Evidence [PDF]
Background: Ceftolozane/tazobactam (C/T) is a β-lactam/β-lactamase inhibitor combination that mainly targets Gram-negative bacteria. The current international guidelines recommend including C/T treatment in the empirical therapy for hospital-acquired ...
Luca Gregorio Giaccari +5 more
doaj +3 more sources
Trends in Antimicrobial Resistance at a Greek Tertiary Hospital over a 7-Year Period, Including the COVID-19 Pandemic [PDF]
Background/Objectives: Antimicrobial resistance (AMR) remains a major global threat, with the COVID-19 pandemic influencing its dynamics, although its overall impact remains uncertain.
Eleni Mylona +9 more
doaj +2 more sources
Efficacy of colistin-based combinations against pandrug-resistant whole-genome-sequenced Klebsiella pneumoniae isolated from hospitalized patients in Egypt: an in vitro/vivo comparative study [PDF]
Background Colistin resistance significantly constrains available treatment options and results in the emergence of pandrug-resistant (PDR) strains. Treating PDR infections is a major public health issue. A promising solution lies in using colistin-based
Eriny T. Attalla +5 more
doaj +2 more sources
Trends of Antibiotic Resistance Patterns and Bacteriological Profiles of Pathogens Associated with Genitourinary Infections in Secondary Healthcare Facilities in the Volta Region of Ghana. [PDF]
Urogenital infections contribute greatly to both hospital- and community-acquired infections. In Ghana, the prevalence of resistance to commonly used antibiotics is relatively high.
Odoi H +15 more
europepmc +3 more sources
Incidence and Antibiotic Susceptibility of Gram-Negative Bacteria Associated With Chest Infections in Intensive Care Unit Patients From a Selected Hospital in the Kingdom of Saudi Arabia. [PDF]
Background Hospital‐acquired pneumonia (HAP), including ventilator‐associated pneumonia (VAP), is a leading cause of morbidity and mortality in intensive care units (ICUs). Local, organism‐specific antimicrobial resistance data are critical to guide empiric therapy and strengthen antimicrobial stewardship efforts.
Almouwlid A +5 more
europepmc +2 more sources
Emergence of ST63 Pandrug-Resistant Acinetobacter pittii Isolated From an AECOPD Patient in China
Acinetobacter sp. is among the ESKAPE organisms which represent the major nosocomial pathogens that exhibited a high resistance rate. A. pittii, frequently associated with antimicrobial resistance particularly to carbapenems, is one of the most common ...
Ling Yang +5 more
doaj +1 more source
Increasing antimicrobial resistance in nosocomial pathogens; multidrug-resistant extensively drug-resistant and pandrug-resistant Acinetobacter baumannii [PDF]
Objective: The aim of this study was to determine the antimicrobial susceptibility of Acinetobacter baumannii strains, which were isolated from nosocomial infections and compare the changes in resistance rates of isolates over time.Methods: Acinetobacter
Cem Celik +5 more
doaj +2 more sources
Pseudomonas aeruginosa is a ubiquitous microorganism that is difficult to treat due to the increasing prevalence of multidrug resistance patterns. A total of 227 samples were taken from different clinical samples during the study period from January 2018 to December 2018. The isolates were identified with antibiotic sensitivity testing with ESBL by the
Fattma A, Ali +3 more
openaire +3 more sources
Background: The increased frequency of bacteraemias caused by pandrug-resistant Klebsiella pneumoniae (PDR-Kp) has significant implications. The aim of the present study was to identify predictors associated with mortality of PDR-Kp bacteraemias. Methods:
Matthaios Papadimitriou-Olivgeris +8 more
doaj +1 more source
The global prevalence of colistin-resistant Klebsiella pneumoniae (ColRkp) facilitated by chromosomal and plasmid-mediated Ara4N or PEtN-remodeled LPS alterations has steadily increased with increased colistin usage for treating carbapenem-resistant K ...
Aye Mya Sithu Shein +28 more
doaj +1 more source

